Molly Kitley, MD
Dermatology · Bloomington, INNPI 1720578131
Payments from drug & device makers
Across 349 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$875
- Sun Pharmaceutical Industries Inc.$703
- Johnson & Johnson$696
- Regeneron Healthcare Solutions, Inc.$491
- UCB, Inc.$489
- Amgen$425
- plus $2K from 16 others
What the payments were for
- Food & beverage$5,45092%
- Education$4698%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 70 | $875 |
| Sun Pharmaceutical Industries Inc. | 34 | $703 |
| Johnson & Johnson | 37 | $696 |
| Regeneron Healthcare Solutions, Inc. | 21 | $491 |
| UCB, Inc. | 31 | $489 |
| Amgen | 23 | $425 |
| Sanofi | 19 | $330 |
| Novartis | 24 | $321 |
| Lilly USA, LLC | 18 | $284 |
| Incyte Corporation | 16 | $268 |
| Galderma Laboratories, L.p. | 9 | $204 |
| LEO Pharma Inc. | 10 | $180 |
| E.r. Squibb & Sons, L.L.C. | 11 | $169 |
| Pfizer | 10 | $163 |
| Boehringer Ingelheim | 4 | $84 |
| Almirall LLC | 2 | $55 |
| ANI Pharmaceuticals, Inc. | 2 | $42 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $40 |
| Biofrontera Inc. | 2 | $40 |
| Arcutis Biotherapeutics, Inc. | 2 | $32 |
| Botanix SB Inc | 1 | $15 |
| Journey Medical Corporation | 1 | $14 |
How this compares
$5,920 in reported general payments places this provider in the 55th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 55 | $203,342 |
| Humira(Cf) PenAdalimumab | 12 | $80,548 |
| Ketoconazole | 254 | $5,369 |
| Clobetasol Propionate | 79 | $4,447 |
| Metronidazole | 42 | $2,734 |
| Triamcinolone Acetonide | 168 | $1,979 |
| Clindamycin Phosphate | 33 | $1,369 |
| Tretinoin | 16 | $1,222 |
| Doxycycline Hyclate | 19 | $731 |
| Mupirocin | 65 | $680 |
| Hydrocortisone | 88 | $643 |
| Ciclopirox | 12 | $631 |
| Doxycycline Monohydrate | 15 | $326 |
| Hydroxychloroquine Sulfate | 15 | $249 |
| Minoxidil | 29 | $168 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Bloomington
- Talley WhangBloomington$13K
- Carrie DavisBloomington$12K
- Mary McTigueBloomington$11K
- Scott GuenthnerPlainfield$10.7M
- Scott FretzinIndianapolis$9.8M
- David RosmarinIndianapolis$4.4M
- Holly Hake HarrisSouth Bend$3.4M
- Megan LandisCorydon$2.8M
- Kenneth DawesIndianapolis$2.2M
- Ginat MirowskiIndianapolis$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.